Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25-hydroxyvitamin D3 and Vitamin D Receptor Target Gene Expression (VitDbol)

NCT02063334 is registered in ClinicalTrials.gov with University of Eastern Finland as lead sponsor.

NCT NCT02063334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02063334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25-hydroxyvitamin D3 and Vitamin D Receptor Target Gene Expression (VitDbol)
Lead sponsor
University of Eastern Finland
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2015
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

serum 25(oh)d concentration, vitamin d receptor target gene expression